Page 608 - Cardiac Nursing
P. 608

009
                                  009
                                     0
                                6/2
                              0/0
                              0/0
                                6/2
                                        3 P
                                          M
                                          M
                                        3 P
                                     0
                                      1:4
                                      1:4
                             3
                      5-5
                        94.
                        94.
                      5-5
                   p
                    55
                    55
                           xd
                              3
                             3
                           xd
                          q
                          q
                          q
                                            Pa
                                                     ara
                                                     ara
                                                    t
                                                   p
                                                    t
                 24_
         LWB
         LWB K34 0-c 24_ p pp555-594.qxd  30/06/2009  01:43 PM  Page 584 Aptara
         LWBK340-c24_
               0-c
            K34
                                                   p
                                              g
                                              g
                                              g
                                              e 5
                                              e 5
                                            Pa
                                                   p
                                                  A
                                                  A
                                                84
                                                84
                  584    PA R T  I V / Pathophysiology and Management of Heart Disease
                  cardiogenic shock, cool, moist skin with barely perceptible periph-  RA pressure; and PA systolic, diastolic, and wedge pressures. The
                  eral pulses is commonly observed. Capillary refill and peripheral  cardiac output is decreased in HF, whereas the RA pressure or cen-
                  pulses are other indicators of the relative adequacy of cardiac out-  tral venous pressure is elevated. The PAWP indirectly measures
                  put. Normal capillary refill is almost instantaneous; in cardiogenic  the LV end-diastolic pressure, which is a measure of end-diastolic
                  shock, capillary refill is often prolonged.          volume or preload and is elevated in HF.
                                                                        Derived parameters that may be obtained by the use of the PA
                  Diagnostic Tools                                    catheter include CI and SVR. Body surface area (BSA), measured
                  The primary measurements that document the relative adequacy  in square meters, is correlated with the volume of cardiac output
                  of blood flow include continuous monitoring of arterial blood  (CO) to establish the CI:
                  pressure and monitoring of the ECG with rhythm analysis. The             CI    CO
                  ECG can be diagnostic in the setting of MI. Most patients in                  BSA
                                                                                              5
                  shock are tachycardic and may show evidence of supraventricular  SVR, measured in dynes/s/cm , reflects the pressure difference
                  or ventricular arrhythmias. Low QRS voltage and/or electrical al-  of the systemic arteries to the veins.
                  ternans can be seen in cardiac tamponade. 199                            MAP RAP
                     Transthoracic echocardiography is an excellent tool to obtain   SVR       CO      80
                  noninvasive information regarding the overall and regional sys-
                  tolic and diastolic function, intravascular volume, cardiac hemo-  Besides offering diagnostic information, hemodynamic vari-
                  dynamics, myocardial abnormalities. 46  Echocardiography can  ables show a strong prognostic value for short-term survival.
                                                                                 201
                  rapidly assess for mechanical causes, such as severe mitral regurgi-  Forrester et al.  classified patients with acute MI into four sub-
                  tation and papillary muscle rupture, acute VSD, free-wall rupture,  sets with different mortality rates (see Fig. 24-18). They showed
                  and tamponade. Predictors of short- and long-term mortality  that clinical signs of hypoperfusion occur with a CI of less than
                                                                                   2
                  from cardiogenic shock relate to the LVEF and mitral regurgita-  2.2 L/min per m and clinical signs of pulmonary congestion
                  tion on presentation, supporting early use of echocardiography in  occur with a PAWP greater than 18 mm Hg. Subset I shows a
                  the course of cardiogenic shock. 46                 patient with normal CI and normal PAWP with no evidence of
                     Chest radiography may suggest a specific diagnosis. Continu-  pulmonary congestion or peripheral hypoperfusion (warm and
                  ous measurement of urine output and mental status are good in-  dry). Subset III shows a patient with a low CI and PAWP, re-
                  dicators of adequate organ perfusion. A complete blood count and  flecting peripheral hypoperfusion without pulmonary conges-
                  serial cardiac enzymes should be obtained. Serial measurements of
                  arterial blood gases reflect the overall metabolic state of the pa-
                  tient, the adequacy of ventilation, and the adequacy of the circu-
                  lation in providing for oxygen and metabolic needs. Measurement
                  of mixed venous oxygen content (  ) by direct blood sampling
                  or by continuous invasive monitoring reflects peripheral oxygen
                  extraction and use. Serial arterial lactate levels can also be meas-
                  ured because the presence of lactic acidosis helps identify critical
                  hypoperfusion as marked by anaerobic metabolism. 46
                     Measurement of serum BNP has become a recent laboratory
                  value that is measured as a means to identify those patients with
                  LV dysfunction 28  (see Figure 24-11). Elevation of other sub-                    Warm and wet
                                                                                 Warm and dry
                  stances in the blood that reflect the function of specific organs,
                  such as  blood urea nitrogen, creatinine,  bilirubin, aspartate
                  aminotransferase, and lactate dehydrogenase, may be useful in the
                  diagnosis of shock.
                     In seriously ill patients, direct determination of intra-arterial
                  pressure with an arterial line is necessary because systemic arterial
                  pressure determines the perfusion pressure of various organ sys-
                  tems and is predominantly the product of cardiac output and                        Cold and wet
                  SVR. In HF, a drop in cardiac output is compensated for by an in-  Cool and dry
                  creased SVR in an attempt to maintain the arterial blood pressure
                  in normal range.
                     Right-sided heart catheterization with a PA quadruple lumen
                  thermodilution catheter can aid in the diagnosis and assessment of
                  the severity of HF  (Chapter 21). This invasive hemodynamic
                  monitoring can be useful in excluding volume depletion, RV in-
                  farction, and mechanical problems (e.g., acute mitral regurgita-
                  tion). It is also useful for monitoring the response to treatment
                  (including volume, diuretics, inotropic support, vasoactive agents,
                  natriuretic peptide) and manipulation of the variables of cardiac
                  output, preload, and afterload. 190  The hemodynamic variables  ■ Figure 24-18 Forrester subsets: clinical states and therapy. IABP,
                  measured by this catheter are cardiac output by thermodilution;  intra-aortic balloon pumping.
   603   604   605   606   607   608   609   610   611   612   613